Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 04 07 2020
accepted: 09 11 2020
pubmed: 29 11 2020
medline: 15 12 2021
entrez: 28 11 2020
Statut: ppublish

Résumé

Vasoplegia often complicates on-pump cardiac surgery. Systemic inflammatory response induced by extracorporeal circulation represents the major determinant, but adrenal insufficiency and postoperative vasopressin deficiency may have a role. Pathophysiological meaning of perioperative changes in endocrine markers of hydro-electrolyte balance has not still fully elucidated. Objectives of the present research study were to estimate the incidence of vasoplegia in a homogeneous cohort of not severe cardiopathic patients, to define the role of presurgical adrenal insufficiency, to evaluate copeptin and NT-proBNP trends in the perioperative. We conducted a prospective cohort study in the cardiac intensive care unit of a tertiary referral center. We evaluated 350 consecutive patients scheduled for cardiac surgery; 55 subjects completed the study. Both standard and low-dose corticotropin stimulation tests were performed in the preoperative; copeptin and NT-proBNP were evaluated in the preoperative (T0), on day 1 (T1) and day 7 (T2) after surgery. Nine subjects (16.3%) developed vasoplegic syndrome with longer bypass and clamping time (p < 0.001). Reduced response to low-dose ACTH test was not associated to vasoplegia. Preoperative copeptin > 16.9 pmol/L accurately predicted the syndrome (AUC 0.86, 95% CI 0.73-0.94; OR 1.17, 95% CI 1.04-1.32). An evident correlation was observed at 7 days postoperative between NT-proBNP and copeptin (r 0.88, 95% CI 0.8-0.93; p < 0.001). Preoperative impaired response to low-dose ACTH stimulation test is not a risk factor for post-cardiotomic vasoplegia; conversely, higher preoperative copeptin predicts the complication. On-pump cardiac surgery could be an interesting model of rapid heart failure progression.

Identifiants

pubmed: 33247422
doi: 10.1007/s40618-020-01465-5
pii: 10.1007/s40618-020-01465-5
pmc: PMC8195887
doi:

Substances chimiques

Biomarkers 0
Glycopeptides 0
Peptide Fragments 0
copeptins 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1533-1541

Références

J Thorac Cardiovasc Surg. 1998 Dec;116(6):973-80
pubmed: 9832689
Circulation. 2009 Oct 27;120(17):1664-71
pubmed: 19822810
Crit Care. 2018 Jul 6;22(1):174
pubmed: 29980217
Crit Care Med. 1998 Nov;26(11):1793-800
pubmed: 9824069
N Engl J Med. 2001 Aug 23;345(8):588-95
pubmed: 11529214
Crit Care Med. 2003 Apr;31(4):1068-74
pubmed: 12682474
J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022
pubmed: 29223724
Ann Thorac Surg. 2003 Mar;75(3):926-30
pubmed: 12645718
Anesthesiology. 2017 Jan;126(1):85-93
pubmed: 27841822
Heart. 2017 Oct;103(20):1569-1577
pubmed: 28689178
J Card Fail. 2007 Feb;13(1):42-9
pubmed: 17339002
Neuro Endocrinol Lett. 2008 Jun;29(3):341-6
pubmed: 18580851
J Cardiothorac Vasc Anesth. 2018 Oct;32(5):2225-2232
pubmed: 29748077
Cardiovasc Res. 2001 Aug 15;51(3):495-509
pubmed: 11476740
Neuroendocrinology. 2020;110(6):525-534
pubmed: 31484187
Eur J Cardiothorac Surg. 2008 Oct;34(4):820-5
pubmed: 18715792
J Cell Biochem. 2018 Nov;119(10):7913-7923
pubmed: 30011137
Crit Care. 2007;11(2):R31
pubmed: 17331245
Best Pract Res Clin Endocrinol Metab. 2003 Dec;17(4):471-503
pubmed: 14687585
J Am Coll Cardiol. 1992 May;19(6):1180-4
pubmed: 1532971
Intensive Care Med. 2009 Mar;35(3):489-97
pubmed: 18825368
J Crit Care. 2012 Oct;27(5):528.e1-6
pubmed: 22341724
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
J Card Surg. 2019 Jan;34(1):20-27
pubmed: 30597665
Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13
pubmed: 10456395
Physiol Rev. 2004 Jan;84(1):169-208
pubmed: 14715914
Clin Chem. 2006 Jan;52(1):112-9
pubmed: 16269513
Chest. 2002 Nov;122(5):1784-96
pubmed: 12426284
Crit Care. 2011;15(5):R255
pubmed: 22026977
J Clin Anesth. 2017 Aug;40:63-71
pubmed: 28625450
Intensive Care Med. 2018 Apr;44(4):474-477
pubmed: 29090327

Auteurs

D Pasero (D)

Anaesthesia and Critical Care Medicine, Department of Medical, Surgical and Experimental Science, University Hospital, University of Sassari, Sassari, Italy. danielacristina.pasero@gmail.com.

A M Berton (AM)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

G Motta (G)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

R Raffaldi (R)

Department of Surgical Science, University of Turin, Turin, Italy.

G Fornaro (G)

Department of Anesthesiology, Critical Care and Emergency Medicine, Cardiac Intensive Care Unit, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

A Costamagna (A)

Department of Anesthesiology, Critical Care and Emergency Medicine, Cardiac Intensive Care Unit, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

A Toscano (A)

Department of Anesthesiology, Critical Care and Emergency Medicine, Cardiac Intensive Care Unit, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

C Filippini (C)

Department of Surgical Science, University of Turin, Turin, Italy.

G Mengozzi (G)

Clinical Biochemistry Laboratory, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

N Prencipe (N)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

M Zavattaro (M)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

F Settanni (F)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

E Ghigo (E)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

L Brazzi (L)

Department of Surgical Science, University of Turin, Turin, Italy.
Department of Anesthesiology, Critical Care and Emergency Medicine, Cardiac Intensive Care Unit, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

A S Benso (AS)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University Hospital "Città della Salute e della Scienza di Torino", Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH